Takeda Pharmaceuticals International GmbH

Industry / private company


Location: Zürich, Switzerland (CH) CH

ROR: https://ror.org/002ysmy84

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Preferences, attitudes and views regarding genetic newborn screening (gNBS) for rare diseases: a systematic review of the literature and synthesis from 2009 to 2022 (2026) Martin S, Kyosovska-Peshtenska G, Audi J, Zarakowska K, Grauman Å, Veldwijk J, Hauber B, et al. Journal article, Review article Efficacy and health-related quality of life associated with second-line vedolizumab after first-line treatment with one anti-TNF in patients with ulcerative colitis: a meta-analysis of the GEMINI-1 and VISIBLE-1 trials (2026) Atreya R, Kirchgesner J, Cheah Z, Biedermann P, Bakker L, Meyer M, Raine T Journal article Patient preferences in genetic newborn screening for rare diseases: study protocol (2024) Martin S, Angolini E, Audi J, Bertini E, Bruno LP, Coulter J, Ferlini A, et al. Journal article Genetic newborn screening and digital technologies: A project protocol based on a dual approach to shorten the rare diseases diagnostic path in Europe (2023) Garnier N, Berghout J, Zygmunt A, Singh D, Huang KA, Kantz W, Blankart CR, et al. Journal article